Kitabayashi I - Search Results

1

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.

Shinohara H, Sawado R, Nakagawa M, Hattori A, Yamagata K, Tauchi K, Ito J, Kuwahara Y, Okuda T, Ogawa C, Kitabayashi I. Shinohara H, et al. Among authors: kitabayashi i. Mol Ther Oncolytics. 2022 Sep 19;27:14-25. doi: 10.1016/j.omto.2022.09.006. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36212776 Free PMC article.

2

Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX.

Yamagata K, Kitabayashi I. Yamagata K, et al. Among authors: kitabayashi i. Biochem Biophys Res Commun. 2009 Dec 25;390(4):1355-60. doi: 10.1016/j.bbrc.2009.10.156. Epub 2009 Nov 4. Biochem Biophys Res Commun. 2009. PMID: 19895790

3

Roles of AML1/RUNX1 in T-cell malignancy induced by loss of p53.

Shimizu K, Yamagata K, Kurokawa M, Mizutani S, Tsunematsu Y, Kitabayashi I. Shimizu K, et al. Among authors: kitabayashi i. Cancer Sci. 2013 Aug;104(8):1033-8. doi: 10.1111/cas.12199. Epub 2013 Jun 20. Cancer Sci. 2013. PMID: 23679839 Free PMC article.

4

Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.

Shima H, Yamagata K, Aikawa Y, Shino M, Koseki H, Shimada H, Kitabayashi I. Shima H, et al. Among authors: kitabayashi i. Int J Hematol. 2014 Jan;99(1):21-31. doi: 10.1007/s12185-013-1466-x. Epub 2013 Nov 21. Int J Hematol. 2014. PMID: 24258712

5

Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.

Suzuki M, Yamagata K, Shino M, Aikawa Y, Akashi K, Watanabe T, Kitabayashi I. Suzuki M, et al. Among authors: kitabayashi i. Cancer Sci. 2014 Mar;105(3):315-23. doi: 10.1111/cas.12347. Epub 2014 Feb 13. Cancer Sci. 2014. PMID: 24397609 Free PMC article.

6

Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.

Aikawa Y, Yamagata K, Katsumoto T, Shima Y, Shino M, Stanley ER, Cleary ML, Akashi K, Tenen DG, Kitabayashi I. Aikawa Y, et al. Among authors: kitabayashi i. Cancer Sci. 2015 Mar;106(3):227-36. doi: 10.1111/cas.12593. Epub 2015 Feb 12. Cancer Sci. 2015. PMID: 25529853 Free PMC article.

7

[I. Identification of a Possible Therapeutic Target for Chondrosarcoma with IDH Mutant Inhibitors].

Nakagawa M, Nakatani F, Kitabayashi I. Nakagawa M, et al. Among authors: kitabayashi i. Gan To Kagaku Ryoho. 2017 Mar;44(3):212-216. Gan To Kagaku Ryoho. 2017. PMID: 28400543 Japanese. No abstract available.

8

Mllt10 knockout mouse model reveals critical role of Af10-dependent H3K79 methylation in midfacial development.

Ogoh H, Yamagata K, Nakao T, Sandell LL, Yamamoto A, Yamashita A, Tanga N, Suzuki M, Abe T, Kitabayashi I, Watanabe T, Sakai D. Ogoh H, et al. Among authors: kitabayashi i. Sci Rep. 2017 Sep 20;7(1):11922. doi: 10.1038/s41598-017-11745-5. Sci Rep. 2017. PMID: 28931923 Free PMC article.

9

Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia.

Fujita S, Honma D, Adachi N, Araki K, Takamatsu E, Katsumoto T, Yamagata K, Akashi K, Aoyama K, Iwama A, Kitabayashi I. Fujita S, et al. Among authors: kitabayashi i. Leukemia. 2018 Apr;32(4):855-864. doi: 10.1038/leu.2017.300. Epub 2017 Sep 27. Leukemia. 2018. PMID: 28951561

10

Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.

Shima H, Takamatsu-Ichihara E, Shino M, Yamagata K, Katsumoto T, Aikawa Y, Fujita S, Koseki H, Kitabayashi I. Shima H, et al. Among authors: kitabayashi i. Blood. 2018 Apr 19;131(16):1833-1845. doi: 10.1182/blood-2017-05-787226. Epub 2018 Jan 25. Blood. 2018. PMID: 29371181 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters